Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13663
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBrasil. Ministério da Saúde-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.date.accessioned2023-04-25T13:48:26Z-
dc.date.available2023-04-25T13:48:26Z-
dc.date.issued2023-01-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/13663-
dc.description3 p.pt_BR
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno VII, n. 69.-
dc.subjectCarcinoma de Células Renais/diagnósticopt_BR
dc.subjectCarcinoma, Renal Cell/diagnosispt_BR
dc.subjectCarcinoma de Células Renales/diagnósticopt_BR
dc.subjectCarcinoma de Células Renais/terapia-
dc.subjectCarcinoma, Renal Cell/therapy-
dc.subjectCarcinoma de Células Renales/terapia-
dc.titlePortaria conjunta n. 20 /SAES e SCTIE/MS, de 27 de outubro de 2022: aprova as diretrizes diagnósticas e terapêuticas do carcinoma de células renaispt_BR
dc.TypePeriodicalpt_BR
Appears in Collections:Informe SUS - ONCO 2023

Files in This Item:
File Description SizeFormat 
3_Janeiro_2023.pdf451.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.